Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis

Prosthetic valve endocarditis due to Cardiobacterium hominis is rare and recommended therapy includes a third generation cephalosporin. We report a case of Cardiobacterium hominis endocarditis post transcatheter aortic valve replacement in a patient with significant beta-lactam antimicrobial sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Avery, Lisa M., Felberbaum, Catherine B., Hasan, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881436/
https://www.ncbi.nlm.nih.gov/pubmed/29619328
http://dx.doi.org/10.1016/j.idcr.2018.01.016
_version_ 1783311318266150912
author Avery, Lisa M.
Felberbaum, Catherine B.
Hasan, Muhammad
author_facet Avery, Lisa M.
Felberbaum, Catherine B.
Hasan, Muhammad
author_sort Avery, Lisa M.
collection PubMed
description Prosthetic valve endocarditis due to Cardiobacterium hominis is rare and recommended therapy includes a third generation cephalosporin. We report a case of Cardiobacterium hominis endocarditis post transcatheter aortic valve replacement in a patient with significant beta-lactam antimicrobial sensitivities who was successfully treated with ciprofloxacin monotherapy in conjunction with surgery.
format Online
Article
Text
id pubmed-5881436
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58814362018-04-04 Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis Avery, Lisa M. Felberbaum, Catherine B. Hasan, Muhammad IDCases Article Prosthetic valve endocarditis due to Cardiobacterium hominis is rare and recommended therapy includes a third generation cephalosporin. We report a case of Cardiobacterium hominis endocarditis post transcatheter aortic valve replacement in a patient with significant beta-lactam antimicrobial sensitivities who was successfully treated with ciprofloxacin monotherapy in conjunction with surgery. Elsevier 2018-02-06 /pmc/articles/PMC5881436/ /pubmed/29619328 http://dx.doi.org/10.1016/j.idcr.2018.01.016 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Avery, Lisa M.
Felberbaum, Catherine B.
Hasan, Muhammad
Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
title Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
title_full Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
title_fullStr Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
title_full_unstemmed Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
title_short Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis
title_sort ciprofloxacin for the treatment of cardiobacterium hominis prosthetic valve endocarditis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881436/
https://www.ncbi.nlm.nih.gov/pubmed/29619328
http://dx.doi.org/10.1016/j.idcr.2018.01.016
work_keys_str_mv AT averylisam ciprofloxacinforthetreatmentofcardiobacteriumhominisprostheticvalveendocarditis
AT felberbaumcatherineb ciprofloxacinforthetreatmentofcardiobacteriumhominisprostheticvalveendocarditis
AT hasanmuhammad ciprofloxacinforthetreatmentofcardiobacteriumhominisprostheticvalveendocarditis

Ejemplares similares